Impacts of surgical interventions on the long-term outcomes in individuals with trisomy 18
Chiaki Iida1, Jun Muneuchi1, Junko Yamamoto1
1Department of Pediatrics, Japan Community Healthcare Organization Kyushu Hospital, 1-8-1, Kishinoura, Yahatanishiku, Kitakyushu, 806-8501, Japan.
Insights
Surgical interventions in trisomy 18 (T18) patients do not improve long-term survival but can enhance the ability to achieve homecare. This study analyzed 69 T18 individuals, comparing surgical versus conservative treatment outcomes.
Area of Science:
- Medical research
- Pediatric surgery
- Genetics and rare diseases
Background:
- Trisomy 18 (T18) is a severe genetic disorder associated with significant morbidity and mortality.
- The role of surgical interventions in improving long-term outcomes for individuals with T18 remains unclear.
- Congenital anomalies, particularly heart defects, are common in T18 patients, often necessitating medical and surgical consideration.
Purpose of the Study:
- To investigate the impact of surgical interventions on long-term survival and homecare achievement in individuals with trisomy 18.
- To compare outcomes between T18 patients who received surgical treatment versus those who received conservative management.
Main Methods:
- Retrospective analysis of 69 individuals with trisomy 18 admitted to four tertiary neonatal centers (2003-2017).
- Patients were categorized into two groups: those undergoing surgical interventions (cardiac, digestive) and those receiving conservative treatment.
- Comparison of survival rates and rates of achieving homecare between the two groups, with Cox hazard analysis for prognostic factors.
Main Results:
- No significant difference in survival rates was observed between the surgical and conservative treatment groups (p=0.26).
- Surgical interventions were associated with a significantly higher rate of achieving homecare (p=0.02).
- Prenatal diagnosis, cardiac surgery, and digestive surgery were identified as factors related to achieving homecare.
Conclusions:
- Aggressive surgical interventions in trisomy 18 patients do not enhance long-term survival.
- Surgical interventions may positively influence the ability of individuals with trisomy 18 to achieve homecare.
- Further research is warranted to delineate the specific benefits and risks of surgical approaches in this population.
Objective:
We aim to clarify whether surgical interventions can contribute to improve the long-term outcomes among individuals with trisomy 18.
Methods:
We retrospectively studied 69 individuals with trisomy 18 admitted to 4 tertiary neonatal centers between 2003 and 2017. A cohort was divided into two groups: subjects with surgical interventions and conservative treatments. We compared the rates of survival and achieving homecare between the groups.
Results:
Gestational age and birth weight were 37 (27-43) weeks and 1,700 (822-2,546) g, respectively. There were 68 patients with congenital heart disease and 20 patients with digestive disease. Surgical interventions including cardiac and digestive surgery were provided in 41% of individuals. There was no difference in gestational age (p=0.30), birth weight (p=0.07), gender (p=0.30), and fetal diagnosis (p=0.87) between the groups. During the median follow up duration of 51 (2-178) months, overall survival rates in 6, 12 and 60 months were 57%, 43% and 12%, respectively. Survival to hospital discharge occurred in 23 patients, and the rates of achieving homecare in 1, 6, and 12 months are 1%, 18% and 30%, respectively. There was no significant difference in survival rate (p=0.26) but in the rate of achieving home care (p=0.02) between the groups. Cox hazard analysis revealed that prenatal diagnosis (hazard ratio 0.30, 95%CI: 0.13-0.75), cardiac surgery (hazard ratio 2.40, 95%CI:,1.03-5.55), and digestive surgery (hazard ratio 1.20, 95%CI: 1.25-3.90) were related to the rate of achieving homecare.
Conclusion:
Aggressive surgical interventions contribute not to the long-term survival but to achieve homecare among individuals with trisomy 18.
Evidence Level:
Level 3 (Prognostic study, Case-Control study).
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Meiosis I
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Teratogenicity


